#REChallenge
Now let’s see you do it on Carnage. (Ain’t nobody doing it on carnage. I would’ve loved to but you can’t rechallenge in the thunderdome until you’ve faced them on that difficulty and that busy work is noooooot fun enough to redo.)
November 13, 2026 at 12:13 AM
WO2026228774A1 describes LaNova's CDH17-gated 4-1BB agonist. Lead construct 135B2E11-263-1-3-1 achieved EC50s of 0.021–0.125 nM; three mice were tumour-free after treatment and rechallenge, supporting tumour-conditional costimulation.
November 12, 2026 at 2:35 PM
The phase 2 SWITCH trial found rechallenging metastatic #BreastCancer that is refractory to #ADCs with novel agents targeting alternative antigens resulted in limited response.
#AntibodyDrugConjugates #MetastaticBreastCancer #mBC #BreastOnc #Oncology

Read more:
www.docwirenews.com/post/cross-r...
Results from the SWITCH Trial | Breast Cancers Today
Alternative-antigen ADC rechallenge with the same payload class showed limited activity in ADC-refractory mBC.
www.docwirenews.com
November 11, 2026 at 2:27 AM
3/3 Novel dengue serotype 4 live virus human challenge: a phase 1 dose optimisation and homologous rechallenge study.

Lancet Microbe · 29 Oct 2026
doi.org/10.1016/j.lanmic.2026.101542
November 4, 2026 at 4:13 PM
New research article

Novel #dengue serotype 4 live virus human challenge: a phase 1 dose optimisation and homologous rechallenge study

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #MicroSky #ViroSky #OpenAccess #OA
October 29, 2026 at 1:46 PM
#ESMO26: Preliminary data support encorafenib and cetuximab #rechallenge in metastatic colorectal cancer (#mCRC), although questions remain around patient selection and treatment specifications, as discussed by Rona Yaeger

🔗 https://ow.ly/6bmH5100p2M

#InsightsbyESMO
October 29, 2026 at 2:10 PM
Nerandomilast-Associated Pneumonitis With a Positive Rechallenge: A Case Report
onlinelibrary.wiley.com/doi/10.1002/...
https://onlinelibrary.wiley.com/doi/10.1002/rcr2.70786
onlinelibrary.wiley.com
October 26, 2026 at 2:00 AM
Sublethal whole body irradiation impairs the kinetics, subset composition, and function of memory CD4 T cells, compromising their ability to mount effective recall responses to clear the infection, affecting patients with a history of radiation exposure. https://ow.ly/rHA250ZZ1VW.
October 21, 2026 at 4:30 PM
Letter to editor
Behavioral tics following sublingual allergen immunotherapy (OSIRIS): A case report
#Allergenic #Immunotherapy #Sublingual #Allergen-specific-immunotherapy #Tic-disorders #Rechallenge

www.em-consulte.com/article/1846...
Behavioral tics following sublingual allergen immunotherapy (OSIRIS): A case report
Behavioral tics following sublingual allergen immunotherapy (OSIRIS): A case report
www.em-consulte.com
October 16, 2026 at 6:54 AM
Rechallenge the flying gym, dude pulls out Dragonite, Aerodactyl, Salamence, Vespiqueen, Drifblim, Yanmega, and dares you to call it unfair
October 14, 2026 at 3:38 PM
I do enjoy the concept in later games/certain fanhacks that they clearly have a team tuned for an appropriate beginner challenge, and when you rechallenge them they pull out all the stops to trip up their normal hard counters, like TM moves and strange/rare 'mon choices.
October 14, 2026 at 3:35 PM
The Legend of Zelda: Ocarina of Time remake features a new Hall of Fallen Foes enemy gallery
The Legend of Zelda: Ocarina of Time remake features a new Hall of Fallen Foes enemy gallery
The Hall of Fallen Foes allows players to examine defeated enemies and rechallenge boss fights.
dlvr.it
October 14, 2026 at 2:24 PM
WO2026205975A1 - a TROP2-targeted IFNβ fusion designed to bypass ADC resistance and stimulate antitumour immunity. ABN202 induced complete responses; 3/5 responders resisted tumour rechallenge, suggesting durable immune memory. Tumour selectivity and normal-tissue toxicity remain key questions.
October 10, 2026 at 9:03 AM
Hear me out -

Should I rechallenge the 100 Character Drawing, but only in doodle-fy style headshot like this for this week's Art-Thursday?

If interested, drop your PNG and imma draw as many as I can
October 7, 2026 at 2:45 AM
If I beat ch 3 I can rechallenge him?
October 6, 2026 at 1:35 AM
📢 New Review in #LiversMDPI

🧬 Vemula et al. review second- and third-line strategies after ICI failure in HCC.

🩺 TKIs remain the most widely used second-line option, while evidence for ICI rechallenge remains limited.

📖 Read More: www.mdpi.com/2673-4389/6/...

#HCC #TKIs
October 5, 2026 at 11:10 AM
Bruh you can't downplay that run, it definitely counts.

And yeah they told me I have to rechallenge if I want to claim reigning Champ as like, a position... When I won the first time they told I was too young and I needed to come back older. Bunch of bs, honestly! I'm gonna do it undefeated
October 1, 2026 at 1:02 AM
I went to go claim my Champion job now that I'm not 15 and they told me I had to rechallenge?? Very unclear if they meant the whole League or what, so I guess I'm on New Game Plus.
September 29, 2026 at 4:51 AM
also the Dancer Resonant was SOOOOOOOOOOO much fun omg I hope there's a way to rechallenge these bosses
September 27, 2026 at 2:47 PM
Ophthopedia Update: Combined Infliximab and Tofacitinib Therapy for Severe Refractory Juvenile Idiopathic Arthritis Associated Panuveitis: A Challenge, Dechallenge, Rechallenge Case Report: .
Combined Infliximab and Tofacitinib Therapy for Severe Refractory Juvenile Idiopathic Arthritis Associated Panuveitis: A Challenge, Dechallenge, Rechallenge Case Report
.
dlvr.it
September 27, 2026 at 10:21 AM
🚨 DAY 2 | #GUARDSymposium2026 Coverage by OncoAlert
After progression, what's the right next line—TKI, IO rechallenge, or a HIF-2a combination? The evidence isn't equal across options. 🧭

At #GUARDSymposium2026, Dr. Javier Molina 🇪🇸, Servicio de Oncología Médica, Hospital Universitario Ramón y Cajal
September 17, 2026 at 1:45 PM
Neuropenia (low neutrophils, a type of white blood cell) can be caused by rituximab as a treatment of multiple sclerosis even many years after taking the medication (image shows neutrophil count vs. days since onset of neutropenia) . pubmed.ncbi.nlm.nih.gov/42743451/
Late-Onset Neutropenia After Rituximab in Multiple Sclerosis: Incidence, Predictors, and Outcomes in a Retrospective Multicenter Cohort - PubMed
In this large real-world cohort, high-grade LON (grades 3-4) events were rare and frequently complicated by infections. Mild (grade 2) LON events were often fluctuating and generally clinically uneventful. Rechallenge with rituximab was rarely complicated by serious adverse events. Prediction of LON …
pubmed.ncbi.nlm.nih.gov
September 16, 2026 at 9:08 PM
September 15, 2026 at 6:27 PM
the guy goes "hah!! I beat you!! I'm going to run away and not let you rechallenge me so I can keep my win over you!!" and that's his final appearance in the entire series
September 15, 2026 at 2:25 AM